here is the official release from Moderna

来源: fuz 于 2020-12-01 07:24:47 [] [博客] [旧帖] [给我悄悄话] 本文已被阅读： 次 (1057 bytes)
本文内容已被 [ fuz ] 在 2020-12-01 07:27:57 编辑过。如有问题，请报告版主或论坛管理删除.

https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-primary-efficacy-analysis-phase-3-cove-study

Today’s primary analysis was based on 196 cases, of which 185 cases of COVID-19 were observed in the placebo group versus 11 cases observed in the mRNA-1273 group, resulting in a point estimate of vaccine efficacy of 94.1%. A secondary endpoint analyzed severe cases of COVID-19 and included 30 severe cases (as defined in the study protocol) in this analysis. All 30 cases occurred in the placebo group and none in the mRNA-1273 vaccinated group. There was one COVID-19-related death in the study to date, which occurred in the placebo group.

 

 

 

所有跟帖： 

• 有了原文，意思就更清楚 -杨别青- ♂ 给 杨别青 发送悄悄话 杨别青 的博客首页 (0 bytes) () 12/01/2020 postreply 10:33:30

请您先登陆，再发跟帖！

发现Adblock插件

如要继续浏览
请支持本站 请务必在本站关闭Adblock

关闭Adblock后 请点击

请参考如何关闭Adblock

安装Adblock plus用户请点击浏览器图标
选择“Disable on www.wenxuecity.com”

安装Adblock用户请点击图标
选择“don't run on pages on this domain”